Intravenous human immunoglobulin (Rockefeller University)
静注人免疫球蛋白（Rockefeller University）
Report date: 2022/05/20 16:06:12
Base Information
Drug NameIntravenous human immunoglobulin (Rockefeller University)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesThe Rockefeller University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A